Biopharmas Manage To Deal During Pandemic
BIO 2020 Panel Suggests Driving Factors For Deal-Making Remain The Same
M&A activity faces numerous hurdles during the COVID-19 pandemic but companies are finding different ways to negotiate, conduct due diligence and get deals completed, BIO 2020 speakers said.
